GlassScriptPhysician profile
Amanda Hasty
NPI 1245933209
$909.38
in general payments reported to CMS, 2019-2025
9 companies · $784 in 2025
The $784 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $125 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $246.26 | 2024-2025 | Krystexxa |
| Linvatec Corporation | $148.30 | 2025 | 5ms, Biobrace 23mm |
| Vertex Pharmaceuticals Incorporated | $147.62 | 2025 | |
| Convatec INC. | $120.97 | 2025 | |
| Medtronic, INC. | $102.54 | 2025 | Intellis Adaptivestim |
| Stryker Corporation | $64.53 | 2025 | Easyfuse, Ortholoc 2 Lapifuse, Actishield |
| Smith+Nephew, INC. | $44.99 | 2025 | Renasys |
| Mf Med | $18.91 | 2025 | |
| Btg International INC. | $15.26 | 2025 | Aurlumyn |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hasty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.